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1. Introduction 
Epithelial ovarian cancer (EOC) is the 5th leading cause of death from cancer in women and 
the main cause of death from gynecological cancer (Barber, 1986). Women have a lifetime 
risk of ovarian cancer of around 1.5%, which makes it the second most common gynecologic 
malignancy after breast cancer. Ovarian cancer is often referred to as 'the silent killer' 
because it frequently causes non-specific symptoms, which contribute to diagnostic delay, 
diagnosis in a late stage and a poor prognosis. This is one of the reasons for the relatively 
low, approximately 40%, 5-year survival rate for women diagnosed with advanced EOC. 
However, when EOC is diagnosed at an early stage this rate increases up to 95% (McGuire et 
al., 2000). This enhancement demonstrates that early detection of EOC is crucial and it is 
vital to develop novel diagnostic methods for higher throughput screening of human 
samples and new biomarkers discovery. 
One of the important and promising strategies for early cancer diagnosis relies on the 
development of approaches that can provide accurate detection and identification of specific 
protein-biomarkers in the serum. These protein-biomarkers would be measured and 
monitored to yield specific signatures that can be used for the early detection of the disease. 
Recently, numerous reports demonstrated that a single biomarker (example: CA 125, 
biomarker of ovarian cancer) approach is highly unlikely to yield results that can accurately 
distinguish cancer samples from healthy ones. This led researchers to explore the idea of 
using a basket of biomarkers (Petricoin et al., 2002; Mor et al., 2005) with the expectation that 
this approach may yield increased specificity and sensitivity for cancer detection. Using this 
approach, G. Mor et al. reported 95% efficiency discrimination between disease-free and 
EOC patients, including patients diagnosed with stage I and II disease (Mor et al., 2005). 
These authors used a blood test, based on the simultaneous identification of four 
biomarkers: leptin, prolactin, osteopontin, and insulin-like growth factor-II. Petricoin et al. 
reported the use of mass spectroscopy to develop a classifier that could identify serum 
from patients with ovarian cancer with 100% sensitivity and 95% specificity (Petricoin et 
al., 2002). In a follow up study, Zhu et al. reported similar results (Zhu, 2003). However, 
questions were raised about tests reproducibility and reliability (Wagner, 2003; Garber, 
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2004). Despite this roller coaster, the need for the development of high-throughput 
methods and multiplexing assays for the simultaneous detection of multiple analytes is 
real (Rubenstein, 2010). 
Several approaches addressing the development of multiplexing assays have been reported 
in recent years. C.A. Mirkin et al. proposed using oligonucleotides as barcodes (DNA 
barcode) and nano-particles aggregates that can alter their physical properties (e.g. optical, 
electrical, mechanical) upon aggregation (Mirkin et al., 2005). The simultaneous 
measurement of serum proteins and sequence-specific oligonucleotide probes by employing 
16 sets of fluorescent microspheres and a flow cytometer has been demonstrated (Fulton et 
al., 1997). Recently, flow injection inductively coupled plasma mass-spectrometry and 
macrocyclic metal chelate complexes loaded with different lanthanides have also been used 
to detect several model peptides and protein (Ahrends et al., 2007). Further, application of 
multicolor quantum dots for molecular diagnostics of cancer was reported (Smith et al., 
2006) and barcodes striped metal nanoparticles were used to provide multiplexed data in 
various bioassays (Freeman et al., 2005). 
Many of the multiplex assays developed recently are based on antigen induced particle 
aggregation (Gosling et al., 1990). Therefore, it is important to strive to better understand the 
aggregation mechanism. Various systems have been employed to study the aggregation 
process. Examples include lipid vesicles (Farbman-Yogev et al., 1998) and metal/metalloid 
particles (Freeman et al., 2005; Smith et al., 2006). A simplified vesicle aggregation theory 
was developed (Farbman-Yogev et al., 1998). This theory deals primarily with vesicles made 
of biotinylated lipid molecules. The presence of streptavidin molecules induces aggregation 
(flocculation). The vesicles are made of amphiphilic molecules combined to form shell-like 
bilayer structures. Therefore, the bonds between lipids and vesicles can be weaker than 
bonds between biotins on lipids and streptavidin molecules in a solution. This theory 
predicts the dissociation of initial cross-linked molecules from the vesicles and their re-
aggregation into preferably smaller aggregates (Farbman-Yogev et al., 1998). 
Particle based immuno-assays have been reviewed in a number of publications (Gosling et 
al., 1990; Smith et al., 2006). Metal and metalloid particles are typically modified with the IgG 
molecules, which are strongly (irreversibly) attached to the surface. The presence of antigen 
molecules induces aggregation. In contrast to lipid vesicles, solid-state particles are unlikely 
to lose the cross-linked molecules and the particle aggregates are more stable (Farbman-
Yogev et al., 1998). From this perspective, the metal and metalloid nano- and micro-particles 
seem more appropriate for developing effective immuno-assays. 
2. Tagging specific proteins: Multi-element coded nano- and micro-particle 
assay 
As discussed above, multiplexing combined with particle-based assay provides an effective 
and promising approach for developing diagnostics. After thorough consideration of 
advantages and disadvantages of the existing technologies briefly described above, we 
present a novel type of assay on a base of multi-element coded nano- and micro-particle tags 
and Laser-Induced Breakdown Spectroscopy (LIBS) as a detection method (Meelikechi and 
Markushin, patent pending). This approach, developed in our laboratory, relies on the use 
of nano- and micro-particles composed of different chemical elements to yield single and 
multi-element code for labeling of the molecules of interest.  
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To illustrate this approach, we show in Figure 1 a schematic of the multi-element coded 
nano- and micro-particle based assay composed of 2 elements: Si and Fe. To perform 
immunoassay we used ovarian cancer biomarkers Leptin and CA 125 with pairs of relevant 
monoclonal antibodies. Monoclonal antibodies were biotinylated prior to performing the 
assay. To mimic blood conditions, all buffers contained about 5% of bovine serum albumin 
(BSA) (Majoor, 1946). For separation of single and aggregated particles we used test tubes 
equipped with 5 µm pore size filters or magnetizing. 
 
 
 
 
Fig. 1. Tag-LIBS experimental schematics. Step a – biotinylation of the group A antibodies 
(M86429M); step b – attaching biotinylated group A antibodies (M86429M) to silicon oxide 
particles modified with streptavidin (suspension B); step c – attaching of the group B 
antibodies (M86306M) to iron oxide particles modified with protein G (suspension A); step 
d - incubation (following by magnetizing and washing) of the mixture of suspensions A and 
B with various concentrations of CA 125. 
Many optical detection techniques developed to perform assays are based on the use of 
fluorescent tags (Zal and Gascoignea, 2004). Although these techniques have many 
advantages, they often suffer from photo bleaching and it is therefore advantageous and 
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useful to explore the development of approaches that do not suffer from such a limitation. 
To do this, it is useful to note that there is a broad class of materials (metals and non-metals), 
which are neither fluorescent nor effectively chemically active. These materials can be 
combined to yield composites that can also be used as tags. This provides a large number of 
possibilities: combining only 11 of such materials (i.e. iron, gold, silver, platinum, 
aluminum, copper, titanium, nickel, zinc, tin and copper) into micro- and nano-particles can 
yield more than 1000 types of different composite particles, some of which are well known 
alloys such as brass (copper and zinc), bronze (copper and tin), and duralumin (aluminum 
and copper). Each of these alloys and composites is unique by chemical content and 
potentially can be used as micro-tags for labeling and detection of ovarian cancer 
biomarkers.  
Below we provide examples of the use of the multi-element coded particle assay for the 
detection of analytes.  
3. Reading the tags: Laser induced-breakdown spectroscopy for early cancer 
diagnosis 
Following the sample preparation described in the previous section, we focus our discussion 
on the detection of the micro- and/or nano-particles attached to the specific biomarkers of 
interest. To perform this step, we use an all-optical technique widely used in many 
applications ranging from space exploration to quality control but only rarely for medical 
applications. This technique, known as Laser Induced Breakdown Spectroscopy (LIBS) is 
well described in the literature and only a brief description is provided in this chapter. For 
more information, we refer the reader to the excellent body of literature available (Cremers 
and Radziemski, 2006, Miziolek et al. 2006, and Markushin et al., 2009).  
LIBS is an analytical technique based on the use of laser pulses intense enough to 
breakdown the chemical bonds of the constituents of a sample to be interrogated. The 
experimental arrangement used in our laboratory is shown in Figure 2. By focusing 
nanosecond long laser pulses onto a sample, a short-lived plasma of the sample is 
generated. These laser pulses ablate a small quantity of the sample - a few hundreds of 
nanograms - located on an automated 3-D translational stage. Light emitted by the plasma 
during cooling is collected by a bundle of optical fibers, which transmits it to a 7-channel 
Ocean Optics LIBS HR2000+ spectrometer (190 - 970 nm) for analysis. The 10 nsec Q-
switched Nd-YAG laser (BM Industries Serie 5000) operating at 1064 nm was used for the 
sample ablation. About 100 laser shots on 100 different spots on a filter were used to collect 
the LIBS spectra. For the purpose of this investigation, we used average laser pulse energies 
of about 70 mJ/pulse, a double convex BK7 focusing lens with a focal length of 70 mm and 
antireflection coating for 1064 nm was positioned at about 61.7 mm distance from the 
surface of the filter. LIBS spectra were obtained at ambient atmospheric conditions. To 
identify the measured atomic and ionic lines, we use the LIBS spectral database developed 
by our group (OSCAR website, n.d., Rock et al., 2008). Potentially, the multi-element coded 
assay is able to detect and identify numerous analytes in parallel with minimum 
interference. This method has the added advantage of requiring as little as a few micro liters 
of serum specimen. More details of the experiment can be found elsewhere (Markushin et 
al., 2009, Rock et al., 2008). 
www.intechopen.com
Sensitive Detection of Epithelial Ovarian Cancer Biomarkers  
Using Tag-Laser Induced Breakdown Spectroscopy 157 
 
 
 
 
 
 
Fig. 2. LIBS experimental set-up consisting of a Nd-YAG Laser pulse laser, prism, focusing 
lens, bundle of light collecting optical fibers, thermoelectric cooler (TEC), a Helium line and 
the Ocean Optics 7-channel spectrometer (OOI spectrometer). 
To implement the multi-element coded approach and demonstrate its potential, we 
prepared and analyzed two-element composite particles (Markushin et al., 2009). We used 
1.5 µm iron oxide biotinylated particles and 3 µm silicon particles with attached avidin. 
First, two types of control experiments (experiments #1 and # 3) were performed. In control 
experiments we checked for the possibility of nonspecific binding of iron oxide biotinylated 
particles to the plastic lab ware components (LIBS spectrum of experiment # 1 on Fig. 3a, 
3b). Nonspecific binding was found to be insignificant. In another control experiment, # 3, 
(Fig. 3a, 3b) iron oxide biotinylated particles were pre-incubated with an excess of avidin 
molecules that allowed neutralizing the biotin groups of iron oxide particles with avidin. 
The following incubation of the neutralized iron oxide particles with Si-avidin particles and 
LIBS analysis demonstrates that nonspecific interactions between both types of micro- 
particles are limited. Some portion of silicon particles with probably bigger than the 3 µm 
particle size can be trapped by 5 µm pore size filter (short-dashed line on Fig. 3a, 3b). This 
was confirmed by additional control experiment with filtering of the 3µm size silicon 
particles over 5 µm pore size filters (data not shown).  
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Fig. 3. LIBS based identification of two-element Fe-Si composite micro-particles. The 
fragment of the LIBS spectrum around 288.1 nm Si line (a). The fragment of the LIBS 
spectrum around 259.9 mn Fe line (b). Solid line – empty filter, dot-dashed line - experiment 
# 1, dashed line - experiment # 2, short-dashed lines - experiment # 3 (adapted from 
(Markushin et al., 2009)) 
The two-element coded composite micro-particles were prepared by allowing the iron oxide 
biotinylated particles to interact with the silicon particles modified by avidin (experiment # 
2). We monitored the amount of aggregates by taking 140 laser shots at the surface of 5 µm 
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pore size centrifuge filters. After overnight incubation the filtrate with unbound micro-
particles was removed by centrifuging over 5 µm pore size filters, then the top part of the 
test tube was cut off and the bottom part with the particles being left on a filter (residue 
particles) was checked by LIBS for the presence of Fe and Si elements (dashed line on Fig. 
3a, 3b). The presence of both Fe (259.9 nm) and Si (288.1 nm) emission lines in the same 
sample proves that we generated the two-element coded composite micro-particles. Thus, 
the ability of LIBS to detect the presence and composition of the micro-particles is 
demonstrated. Further, we suggest that this technique can be employed as a detection 
method for the future element coded assay development. 
Sensitivity is a key factor of any analytical method. To determine the sensitivity of the element-
coded approach, we used the model protein avidin. We performed detection and 
quantification of avidin molecules using LIBS based iron oxide micro-particle assay (Fig. 4). 
The details of the experiment can be found elsewhere (Markushin et al., 2009, Rock et al., 2008). 
1.5 µm iron oxide micro-particles coated with biotin were purchased from Bangs Laboratories 
and their aggregation was induced upon the addition of avidin. We monitored the amount of 
aggregates by using 140 laser shots at the surface of 5 µm pore size centrifuge filters after 
removing the filtrate with non-bound micro-particles. Figure 4 shows the avidin concentration 
dependence of the LIBS based intensity of Fe emission line at 259.9 nm integrated over the 
filter surface. The iron oxide micro-particle assay demonstrated limit-of-detection about 30 ppb 
of avidin. This Figure has a significant maximum at about 155 ppb and is discussed below. 
 
 
Fig. 4. Avidin concentration dependence of the micro- particles aggregation (adapted from 
(Markushin et al., 2009))  
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We employed the element coded LIBS based approach for the detection of biomarker CA 
125. For this particular measurement, we express the concentration of CA 125 in 
International Units (IU or U) per milliliter. Typically these units are used for quantification 
of biologically active substances (e.g. CA 125) instead of grams or moles (World Health 
Organization (WHO) Expert Committee on Biological Standardization, n.d.) According to 
the WHO Expert Committee on Biological Standardization, an International Unit is the 
specific biological activity of a substance, i.e. the quantity of a biologically active molecules 
required to produce a defined response. The use of such internationally accepted units 
ensures that biologically active substances with the same measured response will contain 
the same quantity expressed in International Units. 
We also used the two-element micro-particle coding method to detect ovarian cancer 
biomarker CA 125. To do this, we prepared two bio-suspensions for groups A and B IgG 
antibody tagging (Fig. 1). In suspension B the biotinylated group A antibodies were 
immobilized to the silicon oxide micro particles with streptavidin. In suspension A the 
group B antibodies were immobilized through their Fc (fragment crystallizable region) 
fragments to iron oxide micro particles modified with immunoglobulin-binding protein G. 
Protein G mediates attachment of antibodies to the micro-particles and ensures the proper 
orientation of IgG molecules for the better immuno-assay efficiency (Bjorck & Kronvall, 
1984). The buffer used contained 5% of BSA to mimic blood conditions (Majoor, 1946). 
The following is a step-by-step description of the two-element micro-particle coding assay. 
To perform the analysis on the presence of CA 125 in a solution we follow the following 
procedure:  
Step 1. the monoclonal antibodies M86429M were biotinylated prior to doing assay. EZ-
Link Sulfo-NHS-Biotinylation Kit (Pierce Biotechnology, Inc.) was used for this 
purpose. PBS buffer used for dilutions contained 5% of BSA to mimic blood 
conditions (Fig 1 a).  
Step 2. we prepared suspension B: the 1 µm silicon oxide particles (Bangs Laboratories, 
Inc.) modified with streptavidin were added to the biotinylated monoclonal 
antibodies M86429M solution for overnight incubation at 4° C (Fig 1 b). Following 
incubation, unbound IgG molecules were washed away by three wash-
centrifugation cycles using spin-filters with a pore size about 100 nm (Millipore).  
Step 3. we prepared suspension A by adding the 1.5 µm iron oxide particles (Polysciences, 
Inc.) modified with protein G to the monoclonal antibodies M86306M solution for 
overnight incubation at 4° C (Fig 1 c).  
Step 4. CA 125 solutions of defined concentrations were added to mixtures of suspension A 
and suspension B taken in equal volumes and were incubated and shaken 4 hours 
at room temperature and overnight at 4° C, then were stored at 4° C. For the control 
experiment the PBS buffer with 5% of BSA (no CA 125) was added to a mixture of 
suspension A and suspension B and were incubated and shaken 4 hours at room 
temperature and overnight at 4°C then were stored at 4° C. 
Unbound silicon oxide particles and dissolved CA 125 molecules were separated from 
unbound iron oxide particles and aggregates of iron oxide and silicon oxide particles by 
using strong magnets (residual flux density about 14.5-14.8 KGs (K&J Magnetics, Inc. 
website, n.d.). The separation-washing cycles were repeated 3 times.  
After completing magnetizing and pipetting, the top part of the test tubes was cut off and 
the bottom filters with particles deposited on it (residue particles) were checked by LIBS for 
the presence of Si elements.  
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To obtain better sensitivity, we employed the magnetizing type of assay. In this approach, 
following the incubation, the unbound molecules, the single silicon particles, the single iron 
oxide particles and particle aggregates were separated using strong magnets. After 
completing steps of magnetizing and pipetting, the residue particles left on the filters were 
analyzed using LIBS for the presence of silicon. Fig. 5 shows the fragment of LIBS spectra 
around 288.1 nm silicon emission line obtained by the two-element (Si and Fe) Tag-LIBS 
assay for detection of CA 125 biomarker. The control lowest black line on Fig. 5 was 
obtained from the empty filter. The red line curve is a LIBS spectrum of control sample 
where instead of CA 125 the buffer was added. Other lines represent various concentrations 
of CA 125 in a solution (see Fig. 5). The presence of some Si in the control sample is possibly 
caused by non-specific interaction of micro-particles. 
 
 
Fig. 5. The fragment of LIBS spectra around 288.1 nm silicon emission line in the two-
element (Si and Fe) Tag-LIBS assay for detection of CA 125. The black line represents LIBS of 
the empty filter. Other lines represent various concentrations of CA 125 in a solution: red 
line – control sample with no CA 125, green line – 10 U/ml, blue line – 50 U/ml, light blue 
line - 250 U/ml, pink line – 1000 U/ml. 
Figure 6 shows the experimental results of the ovarian biomarker CA 125 detection by the 
two-element (Fe and Si) Tag-LIBS assay in a blood mimicking PBS buffer. The curve on 
Fig. 6 represents the CA 125 concentration dependence of the intensity of Si emission line 
at about 288.1 nm obtained by Tag-LIBS assay. The experimental curve has a maximum at 
about 10 U/ml and will be discussed later in comparison with results of other 
experiments. 
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Fig. 6. Detection of ovarian cancer biomarker CA 125 by two-element (Si and Fe) micro-
particle Tag-LIBS assay. The curve represents the LIBS intensity of Si emission line in the 
two-element Tag-LIBS assay at the various concentrations of CA 125. 
The two-element (Si-Fe) coded Tag-LIBS assay has been used to analyze the ovarian cancer 
biomarker Leptin. Leptin, IgG monoclonal antibodies H86901M (Group A) and IgG 
H86412M (Group B) monoclonal antibodies to Leptin were purchased from Biodesign 
International. Monoclonal antibodies H86901M and H86412M were biotinylated prior to 
doing assay. EZ-Link Sulfo-NHS-Biotinylation Kit (Pierce Biotechnology, Inc.) was used for 
this purpose.  
Equal amount of 3 µm silicon oxide particles (Kisker Biotech GmbH) and 1.5 µm iron oxide 
particles (Bangs Laboratories, Inc.) were added to pre-mixed solution of defined 
concentration of Leptin and equal concentrations of IgG monoclonal antibodies H86901M 
and IgG monoclonal antibodies H86412M for 3 hour incubation at room temperature and 
overnight at 4° C. Using strong magnets and residual particles on filters assayed, single and 
aggregated particles were separated. We monitored the amount of aggregates in a similar 
way like it was described earlier.  
The intensity of the silicon emission line at about 288.1 nm as a function of the concentration 
of Leptin is shown in Fig. 7 for two independent Tag-LIBS experiments (marked with 
squares and diamonds) performed over with a one-month interval. The reproducibility is 
about 20-30%. The trend line of linear least-square approximation is shown on the figure 
and so is the R-squared coefficient, which is about 0.949. The ascending part of the Tag-LIBS 
assay curve was from 10 to ~ 400 µg/ml. In contrast with CA 125 Tag-LIBS assay (Fig. 6) the 
local maximum feature of the calibration curve for Leptin assay has not been determined in 
the range of concentrations investigated. The presence of Leptin at the level of 11µg/ml has 
been detected by Tag-LIBS approach. 
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Fig. 7. Detection of ovarian cancer biomarker Leptin by two-element (Si and Fe) micro-
particle Tag-LIBS assay in two independent experiments (squares and diamonds) with an 
interval of one month. Solid line is obtained by the linear least squares approximation. 
To ensure the applicability of the Tag-LIBS approach to the clinical environment the human 
fluid with bio-molecules of interest has to be checked. Blood is an extremely complex 
solution composed of plasma with dissolved proteins and blood cells (Cohn, 1948). 
Therefore, human blood plasma and model molecular pair avidin-biotin were chosen to test 
the Tag-LIBS approach for future clinical applications. To maintain homogeneity and 
equivalent conditions for all samples the human blood plasma after thawing has been 
filtered over centrifugal filter with relatively big pore size about 5 µm.  
Two types of particles were used for the assay, i.e. 50 nm gold nano-particles and 1.5 µm 
iron oxide micro-particles. Due to significant differences in size and taking into account the 
densities of gold and iron (we used density of iron instead of combined iron and iron oxide 
density of particle for simplicity), every microgram of gold particles counted for 
approximately 1.4 · 109 nano-particles and every microgram of iron oxide particles included 
about 1.8· 105 micro-particles. Furthermore, the total surface area of 1 µg of gold particles 
was about 6.2· 106 µm2 in comparison with about 7.1· 105 µm2 total surface area of 1 µg of 
iron oxide particles. Thus, to balance the surface areas of the two types of particles, we took 
about 10 times more iron oxide particles (by weight) than gold particles. In addition, the 
concentration of biotin molecules attached to the nano-particles was chosen to be greater 
than the concentration of avidin. Under these conditions, the molecules of avidin are less 
likely to compete for the binding sites, which yields enhanced detection limit.  
Results shown in Fig. 8 demonstrate the ability of the Tag-LIBS approach to detect model 
molecules avidin in human blood plasma. Tag-LIBS analysis has been performed with a 
series of dilutions with the following final concentrations of avidin: 0 ppb, 6 ppb, 64 ppb, 
322 ppb, 644 ppb, 1483 ppb, 2321 ppb, 3224 ppb, and 6448 ppb (curves 0 – 8, Fig. 8). The 
Leptin concentration, µg/ml 
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spectrum of the empty filter was subtracted from the sample spectra. To enhance the clarity 
and viewing of the gold emission peak intensities at 280.2 nm, the sample spectra are 
slightly shifted along the Y-axis (Fig. 8). Data of three Tag-LIBS experiments were averaged 
to plot the control curve (curve 0, Fig. 8). The lowest 6 ppb concentration of model protein 
avidin was measured by Tag-LIBS approach in human blood plasma with about 8:1 signal-
to-noise ratio (curve 1, Fig. 8). 
 
 
Fig. 8. The fragment of background subtracted LIBS spectra around 280.2 nm Gold emission 
line in the two-element (Au and Fe) Tag-LIBS assay for detection of avidin in human blood 
plasma. Concentration of avidin: 0 – 0 ppb (control sample), 1 – 6 ppb, 2 – 64 ppb, 3 – 322 
ppb, 4 – 644 ppb, 5 – 1483 ppb, 6 – 2321 ppb, 7 – 3224 ppb, 8 – 6448 ppb. 
Clearly it is important to maintain, and possibly enhance, the analytical sensitivity of an 
assay while at the same time obtain detection limits that are comparable or better than the 
current attainable. For the CA 125 biomarker the normal level has been previously 
determined, e.g. Niloff et al. (Niloff et al., 1985) have demonstrated that the elevation of 
serum CA 125 concentration over 35 Units/ml (the upper limit of normal) correlates with 
cancer disease progression. For the Leptin biomarker the level below 2.5 ng/ml (the lower 
limit of normal) typically correlates with the presence of cancer (Mor et al., 2005). 
In the proof-of-principle experiments with ovarian cancer biomarkers we achieved about 1 
U/ml detection limit for CA 125 and about 11µg/ml for Leptin. The typical minimum 
detectable concentration of C A125 for solid phase enzyme-linked immunosorbent assays 
(ELISA) was estimated to be from 5 U/ml (Alpha Diagnostic Intl. instruction manual, n.d.) 
to 7 U/ml (Thomas et al., 1995). Therefore, the current Tag-LIBS sensitivity for CA 125 is 
comparable to existing commercial ELISA assays. For ovarian biomarker Leptin more work 
has to be done to improve sensitivity of the current method up to necessary for clinical 
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applications level 2.5 ng/ml. To achieve the goal we plan to use more sensitive gated 
spectrometer (Andor ME 5000 Echelle Spectrograph) with a better spectral resolution. 
Preliminary experiments (data not shown) demonstrated about 20 times improved 
sensitivity for detection of iron oxide micro-particles. Thus, we can expect significant 
improvement of the Tag-LIBS detection limits for biomarkers. 
Figures 4, 6 and 7 show that the binding curves have a local maximum on the calibration 
curves for avidin (Fig. 4) and CA 125 (Fig. 6), but has not been observed for Leptin (Fig. 7). 
In these experiments, three different proteins and protein molecules were investigated. 
These have different molecular weights (mw). The molecule avidin is a tetrameric biotin-
binding protein with molecular weight about 67 KD (UniProt protein database, n.d., a), 
ovarian cancer biomarker CA 125 (also known as mucin 16 or MUC16 (HUGO Gene 
Nomenclature Committee database, n.d.)) has a molecular weight about 2,353 KD (UniProt 
protein database, n.d., b), and Leptin has molecular weight about 18.6 KD (UniProt protein 
database, n.d., c). Proteins with higher molecular weight usually have bigger size (i.e. 
hydrodynamic radius) (Armstrong et al., 2004). Therefore, during the cross-linking process 
the bigger proteins may occupy larger areas and steric effects may take place especially for 
larger proteins (Connolly et al., 2001). This is in agreement with observed Tag-LIBS data 
(Fig. 4, 6, and 7). The presence of local maximum on the calibration curves detected for 
molecules with bigger molecular weight avidin and CA 125 but not for Leptin might be in 
part the result of steric effects and constraints of bio-molecule access to unbound binding 
sites on micro-particles (Connolly et al., 2001) or due to the cross linking critical 
concentration of protein molecules in a solution (Heidelberger, 1933). It is also possible that 
the differences in the experimental protocols (see description above) used for different 
proteins played some role. It is important to mention that the matrix effects accompanying 
LIBS may play a role (Cremers & Radziemski, 2006, B). Further studies are currently 
ongoing. 
Laser-induced breakdown spectroscopy yields integrated data about atomic composition of 
a sample. LIBS can yield more than ten thousand spectral data points for each sample. 
Several methods do exist to reduce the massive amount of data up to the reasonable point. 
The traditional way of analysis involves taking into account the emission spectral 
amplitudes (or areas under the spectral lines) related to few chosen elements of interest 
omitting all other spectral data (Cremers & Radziemski, 2006, B). This leads to plotting 
standard calibration curves to be compared with unknown sample. Another way to reduce 
the amount of experimental data involves the use of the principal component analysis (PCA) 
(Labbe et al., 2008). PCA converts the multi-dimensional set of experimental data into the 
new typically less dimensional set of principal components with higher variance. Several 
classification algorithms such as k-Nearest Neighbor and Support vector machines can be 
further employed (Vance et al., 2010). 
4. Conclusions  
Clearly, it is important to develop novel diagnostic methods for higher throughput 
screening of human samples. Known types of assays for detection of the disease biomarkers 
include enzyme, fluorescence, chemiluminescence, nephelometric and radio- immunoassays 
(Koivunen & Krogsrud, 2006). Encoded particle assays are attracting more attention due to 
their inherent ability for easier scaling-up from the single analyte to highly parallel multi-
analyte systems (Rubenstein, 2010). Such particle based assays are sometimes called virtual 
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arrays to be distinguished from more conventional positional arrays (Rubenstein, 2010). For 
capture entities, the currently employed encoded particle assays use typically antibodies or 
oligo-nucleotides coded by nucleotide sequences or set of dyes (Rubenstein, 2010). Metals, 
non-metals, their alloys and composites have not been used extensively despite the fact that 
they can offer some advantages over traditional coding entities. First, they are chemically 
and biologically inert. They are stable, not harmful for patients, have longer shelf-time and 
relatively easier to handle. 
The choice of proteins to detect is paramount to the diagnostic of cancers (Petricoin et al., 
2002; Mor et al., 2005; Wagner, 2003; Garber, 2004). By employing the multi-element coded 
technique, we offer a novel approach to detect many proteins in serum simultaneously. 
The fundamental question that needs careful attention is: which proteins should be detected 
and monitored? Therefore, the screening for the potential cancer markers becomes crucial 
for the successful diagnostic development. The use of multi-element micro- and nano-
particles labels for possible biomarkers can help in the multiplex biomarker panel 
development.  
Compared with the numerous elemental analytical techniques available, LIBS provides 
many advantages. LIBS method requires much smaller sample volumes and minimal 
sample preparation. It provides real-time spectra, does not require the use of time-of-flight 
devices and is easy to implement. In addition, elements analyzed by LIBS have extremely 
narrow emission bandwidths and characterization of each chemical element, as defined by a 
unique series of emission lines, is highly specific. As a result, LIBS is one of the most 
effective techniques for multi-element analysis of samples. For the Tag-LIBS application the 
identification code is the multi-elemental composition of nano- and micro-particles. 
Using micro-particles for the detection of biomarkers has several advantages compared to 
ELISA micro-titer plates type assays. First, the throughput of the particle assay can be 
greater because of the larger surface-to-volume ratio. Second, the use of mixtures particles 
coated by individual capture molecules allows development of multi-analyte assays. 
Nontoxic and inexpensive labels with minimal interference of background signal and 
improved specific activity, with unique signature appeared to be the most desirable label 
technologies from the viewpoint of industry and academia (Harma, 2002).  
We suggest that the use of LIBS after tagging specific proteins provides a novel approach for 
inexpensive, robust and accurate diagnosis of EOC. In principle, the proposed method is 
applicable for different types of cancer (i.e. ovarian, prostate or lung cancer (Brambilla et al., 
2003)) provided we can identify specific biomarkers. 
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